Caribou Biosciences Stock Price Prediction
| CRBU Stock | USD 1.35 0.04 3.05% |
Momentum 34
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.46) | EPS Estimate Current Year (1.70) | EPS Estimate Next Year (2.10) | Wall Street Target Price 13.25 | EPS Estimate Current Quarter (0.45) |
Using Caribou Biosciences hype-based prediction, you can estimate the value of Caribou Biosciences from the perspective of Caribou Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
Caribou Biosciences Hype to Price Pattern
Investor biases related to Caribou Biosciences' public news can be used to forecast risks associated with an investment in Caribou. The trend in average sentiment can be used to explain how an investor holding Caribou can time the market purely based on public headlines and social activities around Caribou Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Caribou Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Caribou Biosciences.
The fear of missing out, i.e., FOMO, can cause potential investors in Caribou Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Caribou because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Caribou Biosciences after-hype prediction price | USD 1.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Caribou |
Caribou Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Caribou Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Caribou Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Caribou Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Caribou Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Caribou Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Caribou Biosciences' historical news coverage. Caribou Biosciences' after-hype downside and upside margins for the prediction period are 0.07 and 5.44, respectively. We have considered Caribou Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Caribou Biosciences is relatively risky at this time. Analysis and calculation of next after-hype price of Caribou Biosciences is based on 3 months time horizon.
Caribou Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Caribou Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Caribou Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Caribou Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 4.07 | 0.02 | 0.08 | 11 Events / Month | 8 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.35 | 1.37 | 1.48 |
|
Caribou Biosciences Hype Timeline
Caribou Biosciences is currently traded for 1.35. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.08. Caribou is forecasted to increase in value after the next headline, with the price projected to jump to 1.37 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 1.48%, whereas the daily expected return is currently at -0.55%. The volatility of related hype on Caribou Biosciences is about 2839.53%, with the expected price after the next announcement by competition of 1.27. The company reported the previous year's revenue of 34.48 M. Net Loss for the year was (102.07 M) with loss before overhead, payroll, taxes, and interest of (119.49 M). Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out Caribou Biosciences Basic Forecasting Models to cross-verify your projections.Caribou Biosciences Related Hype Analysis
Having access to credible news sources related to Caribou Biosciences' direct competition is more important than ever and may enhance your ability to predict Caribou Biosciences' future price movements. Getting to know how Caribou Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Caribou Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NTLA | Intellia Therapeutics | 0.07 | 11 per month | 0.00 | (0.12) | 7.84 | (7.56) | 22.98 | |
| EDIT | Editas Medicine | 0.03 | 9 per month | 0.00 | (0.19) | 7.02 | (7.94) | 35.85 | |
| CRSP | Crispr Therapeutics AG | (0.59) | 7 per month | 3.42 | 0 | 6.48 | (5.90) | 15.78 | |
| VERV | Verve Therapeutics | (0.10) | 8 per month | 5.27 | 0.1 | 11.24 | (8.35) | 36.90 | |
| BEAM | Beam Therapeutics | (0.43) | 10 per month | 3.77 | 0.08 | 8.04 | (7.94) | 20.93 | |
| FATE | Fate Therapeutics | 0.02 | 9 per month | 0.00 | (0.09) | 11.34 | (11.47) | 34.46 | |
| PRME | Prime Medicine, Common | (0.18) | 6 per month | 0.00 | (0.08) | 9.28 | (8.33) | 19.38 | |
| SANA | Sana Biotechnology | 0.04 | 8 per month | 6.28 | 0.06 | 12.46 | (11.88) | 176.41 | |
| ADPT | Adaptive Biotechnologies Corp | (0.15) | 10 per month | 3.77 | 0.12 | 12.85 | (7.87) | 27.41 |
Caribou Biosciences Additional Predictive Modules
Most predictive techniques to examine Caribou price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Caribou using various technical indicators. When you analyze Caribou charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Caribou Biosciences Predictive Indicators
The successful prediction of Caribou Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Caribou Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Caribou Biosciences based on analysis of Caribou Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Caribou Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Caribou Biosciences's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 9.25 | 11.97 | 10.78 | 7.04 | Net Debt To EBITDA | 0.29 | 0.21 | 0.25 | 0.23 |
Story Coverage note for Caribou Biosciences
The number of cover stories for Caribou Biosciences depends on current market conditions and Caribou Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Caribou Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Caribou Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Caribou Biosciences Short Properties
Caribou Biosciences' future price predictability will typically decrease when Caribou Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Caribou Biosciences often depends not only on the future outlook of the potential Caribou Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Caribou Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.8 M | |
| Cash And Short Term Investments | 328.8 M |
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.